Company: RVRC
Filing Date: 2025-08-13
Form Type: S-1/A
Source: 0001213900-25-075747
Chunk: 59

Company: Revium Rx.
Filing Date: 2025-08-13
Form: S-1/A
Chunk 59
---
| Pro forma as adjusted net                                                         
 tangible book value per share after this offering                                 |     |   |      |     | $ | 0.14 |
| Dilution per share to new investors                                               
 participating in this offering                                                    |     |   |      |     | $ | 3.06 |

The foregoing discussion and table does not take into account further
dilution to investors in this offering that could occur upon the exercise of outstanding options and warrants having a per share exercise
price less than the public offering price per share in this Primary Offering.

<div align='center'>33

MARKET PRICE OF AND DIVIDENDS ON THE COMPANY’S

COMMON EQUITY AND RELATED STOCKHOLDER MATTERS</div>

Market Information

Our Common Stock is quoted on the OTC Pink
under the symbol “RVRC”. Over-the-counter market quotations reflect inter-dealer prices, without retail mark-up, mark-down
or commissions and may not necessarily represent actual transactions. On August 12, 2025, the closing price of our Common Stock was $0.52.
Trading volume in our Common Stock has often been very limited. As a result, the trading price of our Common Stock has been subject to
significant fluctuations. There can be no assurance that a liquid market will develop in the foreseeable future.

We intend to apply to upgrade our Common Stock
to the OTCQB marketplace of the OTC Markets. Among the standard requirements to be eligible for the OTCQB, we must have a public float
of 10% of the total issued and outstanding shares and at least 50 beneficial shareholders each owning at least 100 shares. The Company
must also be required to file reports with the SEC. After the registration statement of which this prospectus is a part of is declared
effective by the SEC, we intend to apply to the OTCQB. Notwithstanding our belief that upon the effective date of this registration statement
our Common Stock will satisfy the admission requirements for the OTCQB and our intention to make application for quotation on the OTCQB
Market, we cannot assure you that our Common Stock will be quoted on the OTCQB tier.

Holders

As of August 12, 2025, there were 118 holders
of record of our Common Stock. The number of record holders does not include an indeterminate number of stockholders whose shares are
held by brokers in street name.

Dividend Policy

We have not paid any dividends since our incorporation
and do not anticipate